Use of (DPP-4) inhibitors linked to increased risk of IBD : BMJ Anjali Nimesh Nimesh21 March 2018 7:31 PM ISTDipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new type of diabetes drug that lower high blood sugar levels. They are usually prescribed...
SGLT-2 inhibitors best for lowering mortality risk in T2DM : JAMA Dr. Kamal Kant Kohli Kohli22 April 2018 8:00 PM ISTThe comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl...
DPP-4 inhibitors best second-line option after Metformin in Diabetes: JAMA Medha Baranwal Baranwal12 Sept 2018 8:10 PM ISTA new research has tried to address the dilemma of choosing best second line drug after Metformin in Diabetes.Sulfonylureas, DPP-4 (dipeptidyl...
Elderly diabetics have lower risk of dementia with DPP 4 inhibitors vs sulfonylureas Vinay Singh singh31 Dec 2018 7:15 PM ISTUse of oral hypoglycemic agent Dipeptidyl peptidase-4 inhibitors (DPP-4i)decreases the risk of dementia compared to sulfonylureas(SU) use in elderly...
